Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Drugmaker to settle nearly 80K Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
GSK says $2.2bn settlement resolves most Zantac litigation
GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the settlements, which will be funded through "existing resources," and said there will be "no changes to GSK's growth agenda or investment plans for R&D as a result."
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer
GSK Settles Zantac Lawsuits: A New Chapter for the Controversial Drug
The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that certain versions might contain impurities linked to cancer,
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now-discontinued version of the heartburn drug caused cancer,
GSK settles 4 Zantac lawsuits claiming heartburn drug caused cancer
GSK announced Wednesday that it has settled four cases in California that were linked to its now-discontinued heartburn drug Zantac. The company didn't disclose a settlement figure.
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
GSK topped the Stoxx Europe 600 index after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer.
GSK shares jump on $2.2 billion Zantac settlement
By Maggie Fick and Yamini Kalia (Reuters) -GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.
devdiscourse
3d
Breaking Health News: Investment Moves, Drug Updates and Disease Outbreaks
This summary covers recent health events including investment in German firm Gerresheimer, updates on the U.S. Medicare drug ...
Medpage Today on MSN
5d
Acne Treatments Taken Right Off the Shelf Had High Levels of Benzene
Dozens of over-the-counter acne products had very high levels of the known carcinogen benzene, even when they were taken ...
Managed Healthcare Executive
9d
2024 PBMI Annual National Conference
Annual National Conference was held Sep. 4-6 in Orlando, Florida. Managed Healthcare Executive is the official publication of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Soldier sentenced to 14 yrs
How to help Milton victims
Free gas for FL residents
Toxic mushrooms poison 11
Israel orders evacuation
Sued by former assistant
Returning to practice
Shooting near TSU
Turtle smuggling guilty plea
Dems shut down AZ office
Says systems were breached
Whooping cough cases rise
SpaceX’s mega rocket feat
Wins Xfinity Series race
Holds rally in California
Tour guide killed in mine
Drug for hemophilia approved
Adds 8 new destinations
Expands sanctions on Iran
FTX exec heads to prison
S&P 500, Dow hit records
Releases medical report
Dodgers advance to NLCS
Gets 2 years for role in riot
Russia cements ties with Iran
Admonishes Black men
To close 444 stores
Gets Walk of Fame star
Feedback